Page last updated: 2024-11-06

cupric nitrilotriacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cupric nitrilotriacetate, also known as copper(II) nitrilotriacetate, is a coordination complex with the formula [Cu(NTA)]-. It is a blue solid that is soluble in water. The compound is used as a copper supplement in animal feed and as a fungicide. Cupric nitrilotriacetate is synthesized by reacting copper(II) ions with nitrilotriacetic acid in aqueous solution. The compound is stable in air and water, but it can decompose in strong acid or base. Cupric nitrilotriacetate is studied for its potential use in agriculture and medicine. It has been shown to be effective in controlling fungal infections in plants and to have antimicrobial activity against bacteria. The compound is also being investigated for its potential use in treating cancer and other diseases.'

cupric nitrilotriacetate: RN given returns to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61819
MeSH IDM0168252

Synonyms (5)

Synonym
cuprate(1-), (n,n-bis(carboxymethyl)glycinato(3-)-n,o,o',o'')-, (t-4)-
cupric nitrilotriacetate
ccris 7802
15844-52-7
copper;2-[bis(carboxylatomethyl)amino]acetate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's7 (58.33)18.2507
2000's3 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.52 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]